The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma
Cancers · 25.01.2023 · 15 (3) · 737
DOI: 10.3390/cancers15030737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 25.01.2023. Verfasst von Yue Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, McGill University, Montreal, QC H4A 3J1, Canada. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Cancer Research Society, Krembil Foundation Grant.
Abstract (Originalsprache)
Receptor-interacting serine/threonine protein kinase 4 (RIPK4) and its kinase substrate the transcription factor interferon regulatory factor 6 (IRF6) play critical roles in the development and maintenance of the epidermis. In addition, ourselves and others have previously shown that RIPK4 is a NOTCH target gene that suppresses the development of cutaneous and head and neck squamous cell carcinomas (HNSCCs). In this study, we used autochthonous mouse models, where the expression of Pik3caH1047R oncogene predisposes the skin and oral cavity to tumor development, and show that not only loss of Ripk4, but also loss of its kinase substrate Irf6, triggers rapid SCC development. In vivo rescue experiments using Ripk4 or a kinase-dead Ripk4 mutant showed that the tumor suppressive function of Ripk4 is dependent on its kinase activity. To elucidate critical mediators of this tumor suppressive pathway, we performed transcriptional profiling of Ripk4-deficient epidermal cells followed by multiplexed in vivo CRISPR screening to identify genes with tumor suppressive capabilities. We show that Elovl4 is a critical Notch-Ripk4-Irf6 downstream target gene, and that Elovl4 loss itself triggers SCC development. Importantly, overexpression of Elovl4 suppressed tumor growth of Ripk4-deficient keratinocytes. Altogether, our work identifies a potent Notch1-Ripk4-Irf6-Elovl4 tumor suppressor axis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
- Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
- Centre for Molecular and Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
- Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1X5, Canada.
- Departments of Experimental Surgery and Experimental Medicine, Faculty of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
- Rosalind and Morris Goodman Cancer Research Institute, McGill University, Montreal, QC H3A 1A3, Canada.
ORCID-Profile: Ahmad Malik, Ricky Tsai
Förderung
- Canadian Institutes of Health Research
- Cancer Research Society
- Krembil Foundation Grant
- MGH Foundation Grant
- International Human Frontier Science Program Organization
- Canadian Institute of Health Research
- Career Development Award from the HFSP
- Scholarships for Next Generation of Scientists (SNGS)
Zitieren
APA
Yan, Y., Gauthier, M. A., Malik, A., Fotiadou, I., Ostrovski, M., Dervovic, D., Ghadban, L., Tsai, R., Gish, G., Loganathan, S. K., & Schramek, D. (2023). The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma. Cancers, 15(3), 737. https://doi.org/10.3390/cancers15030737
Vancouver
Yan Y, Gauthier MA, Malik A, Fotiadou I, Ostrovski M, Dervovic D, et al. The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma. Cancers. 2023;15(3):737. doi:10.3390/cancers15030737
BibTeX
@article{Yan2023,
author = {Yan, Yue and Gauthier, Marc-Andre and Malik, Ahmad and Fotiadou, Iosifina and Ostrovski, Michael and Dervovic, Dzana and Ghadban, Logine and Tsai, Ricky and Gish, Gerald and Loganathan, Sampath Kumar and Schramek, Daniel},
title = {The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {737},
doi = {10.3390/cancers15030737}
}
EUVIMED